Victória Riquena Grosche, PhD is an expert in Virology at Federal University of Uberlândia (Brazil). Victória Riquena Grosche has authored 18 publications, the most recent in 2026. SLR score: 64 (community average: 125). How the SLR is computed.

LeadR Profile

Victória Riquena Grosche, PhD Federal University of Uberlândia Brazil
64 ScienceLeadR Reputation 64
Network Map

Virology

Subspecialties: Infectiology - Pharmacy - Dentistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2020 - 2026
Source: PubMed

Federal University of Uberlândia

2020 - 2026

São Paulo State University

2020 - 2026

Fundação para o Desenvolvimento da UNESP

2024 - 2026

University of Leeds

2025 - 2026

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 18

Citations

Citations: 182 1st author: 4 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Antiviral potential of galactose-binding lectin from Vatairea macrocarpa seeds against SARS-CoV-2.
PMID 42155355 — cells, sars-cov-2, galectins, polysaccharides, drug therapy, seeds, viruses, galactose, research, severe acute respiratory syndrome-related coronavirus, antiviral agents, infections, virus diseases, lectins
Biomed Pharmacother20260
Copper(II) benzyloxychalcone analogues as new potential metallodrugs against SARS-CoV-2 replication.
PMID 42084032 — sars-cov-2, chalcones, virology, viruses, severe acute respiratory syndrome-related coronavirus, antiviral agents
J Gen Virol20260
Lisboaeflavanonol A: a novel Amazonian molecule as a potent antiviral compound with activity against SARS-CoV-2.
PMID 41967233 — cells, sars-cov-2, viruses, plants, medicinal, herbal medicine, severe acute respiratory syndrome-related coronavirus, antiviral agents
Phytomedicine20260
Synthetic Mimotopes of Salivary Peptides against SARS-CoV-2 In Vitro.
PMID 40817788 — cells, sars-cov-2, dentistry, virus replication, covid-19, research, therapeutics, severe acute respiratory syndrome-related coronavirus, cell death, antiviral agents
J Dent Res20250
Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro.
PMID 40415937 — coronavirus, sars-cov-2, virion, covid-19, viruses, peptide hydrolases, severe acute respiratory syndrome-related coronavirus, antiviral agents, rna
Front Microbiol20250

LeadR Networks

Main global connection map